Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14610.00x is 277% below its 1-year average of -3877.40x, near the low end of its 1-year range (-14610.00x–-1.45x).
As of the fiscal period ended Friday, September 30, 2016. 276.80% below its 12-month average of -3877.40x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2016 (2016-09-30): -14610.00x.
INTEREST COVERAGE RATIO
-14610.00x
INTEREST COVERAGE RATIO AVG TTM
-3877.40x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-276.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.80x
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-214952.94%
vs the sector median at left
CRISPR Therapeutics AG
Market Cap
$5.35B
Interest Coverage Ratio
-14610.00x
TTM Avg
-3877.40x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.10B
Interest Coverage Ratio
6.97x
TTM Avg
5.98x
3Y Avg
8.44x
5Y Avg
9.07x
Market Cap
$5.61B
Interest Coverage Ratio
-55.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.47B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.63B
Interest Coverage Ratio
193.28x
TTM Avg
199.58x
3Y Avg
145.92x
5Y Avg
155.47x
Market Cap
$2.76B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$8.02B
Interest Coverage Ratio
-22.52x
TTM Avg
2.41x
3Y Avg
2.41x
5Y Avg
2.41x
Market Cap
$2.52B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | -14610.00x | -3877.40x | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.22B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 6.97x | 5.98x | 8.44x | 9.07x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -55.80x | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.63B | 193.28x | 199.58x | 145.92x | 155.47x |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 7.88x | 5.24x | 5.24x | 5.24x |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | -22.52x | 2.41x | 2.41x | 2.41x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -8.77x | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -358.08x | N/A | N/A | N/A |
Interest Coverage
-14610.0x
Debt/Equity
0.45
Current Ratio
17.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2016-09-30 | -14610.00x |
| 2016-03-31 | -1.45x |
| 2015-12-31 | -122.89x |
| 2015-09-30 | -775.25x |
